WallStreetZenWallStreetZen

NASDAQ: XLO
Xilio Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Xilio Therapeutics earnings were -$31.3M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest XLO earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$9.5M, down 192% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, XLO reported annual earnings of -$35.0M, with -39.8% growth.

XLO earnings history

Current Revenue
$53.5M
Current Earnings
-$31.3M
Current Profit Margin
-58.5%

XLO Return on Equity

Current Company
-117.2%
Current Industry
-142%
Current Market
13.5%
XLO's Return on Equity (-117.2%)... subscribe to Premium to read more.
High Return on Equity Performance

XLO Return on Assets

Current Company
-21.4%
Current Industry
-13.7%
XLO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XLO announces earnings.

XLO Return on Capital Employed

Current Company
-25.97%
Current Industry
-9.5%
XLO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XLO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XLO-$29.91M-$31.30MN/A-$2.55
HYPD-$26.70M-$35.49MN/A-$9.70
ACTU-$21.52M-$21.54MN/A-$0.97
VERU-$13.84M-$13.95MN/A-$0.78
DWTX-$28.09M-$28.32MN/A$0.55
View Top Biotech Stocks

Xilio Therapeutics Earnings Reports & History FAQ

What were Xilio Therapeutics's earnings last quarter?

Xilio Therapeutics (NASDAQ: XLO) reported Q1 2026 earnings per share (EPS) of -$0.58, up 76.71% year over year. Total XLO earnings for the quarter were -$9.53 million. In the same quarter last year, Xilio Therapeutics's earnings per share (EPS) was -$2.49.

If you're new to stock investing, here's how to buy Xilio Therapeutics stock.

Is Xilio Therapeutics profitable or losing money?

As of the last Xilio Therapeutics earnings report, Xilio Therapeutics is currently losing money. Xilio Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$31.30 million, a 42.36% decrease year over year.

What was XLO's earnings growth in the past year?

As of Xilio Therapeutics's earnings date in Q2 2026, Xilio Therapeutics's earnings has grown year over year. XLO earnings in the past year totalled -$31.30 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.